Clinical Trials Browser

Not yet recruiting × INDUSTRY × Prostatic Neoplasms × Clear all

NCT07468396 2026-03-12

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07468708 2026-03-12

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Not yet recruiting

Prostatic Neoplasms

NCT07454603 2026-03-06

PROSTest_STRAT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT07455058 2026-03-06

VAPOR-LTR

Not yet recruiting

Prostatic Neoplasms

NCT07407283 2026-02-12

A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07344779 2026-01-26

ROAD

Not yet recruiting

Prostatic Neoplasms

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

Phase 1/2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07336446 2026-01-13

ANDROMEDA

Phase 1/2 Not yet recruiting

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT07290998 2025-12-18

Treatment of Locally Recurrent Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT06400160 2025-11-25

Clinical Trial of TB511 in Advanced Solid Tumors

Phase 1/2 Not yet recruiting

GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms

NCT07177937 2025-09-22

A Study of DXC014 in Patients With Advanced Solid Tumors.

Phase 1 Not yet recruiting

DermatologicGenitourinaryThoracic

Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT06705686 2025-09-05

PHAROS

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT06607783 2025-08-28

PREDICT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT07104110 2025-08-05

Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT06194461 2025-06-27

LOCUS

Not yet recruiting

GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Prostatic Neoplasms

NCT06765954 2025-05-06

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06765902 2025-05-04

Immunotherapy Before and After Surgery

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06866795 2025-03-10

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT06837896 2025-02-20

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Phase 3 Not yet recruiting

Prostatic Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Phase 1 Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05411354 2024-01-02

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms

NCT06070272 2023-10-06

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms

NCT06009549 2023-08-24

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms